Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 24, 2022Interim analysis showed primary efficacy endpoint of cough reduction was highly statistically significant (p<0.0001) for Haduvio (nalbuphine ER)
Trevi Therapeutics, Inc. (Nasdaq: TRVI) today announced positive interim analysis results of the Phase 2 Cough And NALbuphine (CANAL) trial of its investigational therapy Haduvio™ (nalbuphine...
-
Feb 19, 2022
This is a test from PR Newswire. NEW YORK. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from...
-
Feb 14, 2022
TD Asset Management Inc. ("TDAM") today announced the February cash distributions for the TD Exchange-Traded Funds (the "TD ETFs") listed below. Unitholders of record on February 25, 2022 will...
-
Feb 11, 2022
This is a test from PR Newswire. This is a test from PR Newswire. "This is a test from PR Newswire." This is a test from PR Newswire. 'This is a test from PR Newswire. This is a test from PR...
-
Jan 27, 2022
For the tenth year in a row, several mutual funds managed by TD Asset Management Inc. (TDAM) were recognized at the annual Fundata Canada Inc. (Fundata) FundGrade A+® Awards. Six TD Mutual Funds...
-
Jan 22, 2022
This is a test from PR Newswire. PUBLIC INTEREST. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test...
-
Jan 22, 2022
This is a test from PR Newswire. METALS. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR...
-
Jan 22, 2022
This is a test from PR Newswire. ENTERTAINMENT. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test...
-
Jan 22, 2022
This is a test from PR Newswire. CANNABIS. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from...
-
Jan 22, 2022
This is a test from PR Newswire. AUTOMOTIVE. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from...

